Literature DB >> 26607816

Septic shock in chronic dialysis patients: clinical characteristics, antimicrobial therapy and mortality.

Edward Clark1, Anand Kumar2, Amit Langote1, Stephen Lapinsky3, Peter Dodek4, Andreas Kramer5, Gordon Wood6, Sean M Bagshaw7, Ken Wood8, Dave Gurka9, Manish M Sood10,11.   

Abstract

OBJECTIVES: To describe the clinical characteristics and in-hospital mortality of chronic dialysis-dependent end-stage kidney disease patients with septic shock in comparison to septic shock patients not receiving chronic dialysis.
METHODS: Using an international, multicenter database, we conducted a retrospective analysis of data collected from 10,414 patients admitted to the intensive care unit (ICU) with septic shock from 1989 to 2013, of which 800 (7.7 %) were chronic dialysis patients. Data on demographic characteristics, sites of infection, microbial pathogens, antimicrobial usage patterns, and in-hospital mortality were aggregated and compared for chronic dialysis and non-dialysis patients. Multivariate time-varying Cox models with and without propensity score matching were constructed to determine the association between dialysis and in-hospital death.
RESULTS: Septic shock secondary to central venous catheter infection, peritonitis, ischemic bowel, and cellulitis was more frequent in chronic dialysis patients. The isolation of resistant organisms (10.7 vs. 7.1 %; p = 0.005) and delays in receiving antimicrobials (6.0 vs. 5.0 h) were more common in chronic dialysis patients than in non-dialysis patients. Delayed appropriate antimicrobial therapy was associated with an increased risk of death in chronic dialysis patients (p < 0.0001). In-hospital death occurred in 54.8 and 49.0 % of chronic dialysis and non-dialysis patients, respectively. After propensity score matching, there was no difference in overall survival between chronic dialysis and non-dialysis patients, but survival in chronic dialysis patients decreased over time compared to non-dialysis patients.
CONCLUSIONS: The demographic and clinical characteristics of chronic dialysis patients with septic shock differ from those of similar non-dialysis patients. However, there was no significant difference in mortality between the chronic dialysis and non-dialysis patients with septic shock enrolled in this analysis.

Entities:  

Keywords:  Antimicrobials; Dialysis; Dialysis modality; Epidemiology; In-hospital mortality; Kidney failure; Septic shock

Mesh:

Substances:

Year:  2015        PMID: 26607816     DOI: 10.1007/s00134-015-4147-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  51 in total

Review 1.  Infections associated with uremia and dialysis.

Authors:  V R Minnaganti; B A Cunha
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

2.  Outcomes of chronic dialysis patients admitted to the intensive care unit.

Authors:  Bradford Strijack; Julie Mojica; Manish Sood; Paul Komenda; Joe Bueti; Martina Reslerova; Dan Roberts; Claudio Rigatto
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

Review 3.  Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis.

Authors:  Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

4.  One-year mortality in critically ill patients by severity of kidney dysfunction: a population-based assessment.

Authors:  Sean M Bagshaw; Garth Mortis; Christopher J Doig; Tomas Godinez-Luna; Gordon H Fick; Kevin B Laupland
Journal:  Am J Kidney Dis       Date:  2006-09       Impact factor: 8.860

5.  Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality.

Authors:  L Rojas; P Muñoz; M Kestler; D Arroyo; M Guembe; M Rodríguez-Créixems; E Verde; E Bouza
Journal:  J Hosp Infect       Date:  2013-08-31       Impact factor: 3.926

6.  Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex.

Authors:  A M Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-10       Impact factor: 10.154

7.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

Authors:  M J Sarnak; B L Jaber
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

8.  Systemic inflammatory response syndrome criteria in defining severe sepsis.

Authors:  Kirsi-Maija Kaukonen; Michael Bailey; David Pilcher; D Jamie Cooper; Rinaldo Bellomo
Journal:  N Engl J Med       Date:  2015-03-17       Impact factor: 91.245

9.  Evaluation of definitions for sepsis.

Authors:  W A Knaus; X Sun; O Nystrom; D P Wagner
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Colin A Hutchison; Alex V Crowe; Paul E Stevens; David A Harrison; Graham W Lipkin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  4 in total

1.  Crude reality versus data manipulation: is the glass always crystal clear?

Authors:  Heleen M Oudemans-van Straaten; Jean-Jacques Parienti
Journal:  Intensive Care Med       Date:  2016-01-20       Impact factor: 17.440

2.  The timing of last hemodialysis influences the prognostic value of serum lactate levels in predicting mortality of end-stage renal disease patients with sepsis in the emergency department.

Authors:  Chun Chieh Chu; Chih Min Su; Fu Cheng Chen; Chi Yung Cheng; Hsien Hung Cheng; Chia Te Kung
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

3.  Sepsis in end-stage renal disease patients: are they at an increased risk of mortality?

Authors:  Ralphe Bou Chebl; Hani Tamim; Gilbert Abou Dagher; Musharaf Sadat; Ghassan Ghamdi; Abdulrahman Itani; Alawi Saeedi; Yaseen M Arabi
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

4.  Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats.

Authors:  Chih-Hung Chen; Ben-Chung Cheng; Kuan-Hung Chen; Pei-Lin Shao; Pei-Hsun Sung; Hsin-Ju Chiang; Chih-Chao Yang; Kun-Chen Lin; Cheuk-Kwan Sun; Jiunn-Jye Sheu; Hsueh-Wen Chang; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.